Spots Global Cancer Trial Database for amivantamab 1400mg
Every month we try and update this database with for amivantamab 1400mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations | NCT05845671 | Lung Cancer Non Small Cell ... | Amivantamab 105... Amivantamab 140... Amivantamab (to... Amivantamab (to... | 18 Years - 90 Years | University of Colorado, Denver |